Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Investors overview.gif
Investor Relations Contact:
ir@anacor.com
Phone: 650-543-7575

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Anacor Pharmaceuticals, Inc.'s financial performance into perspective.

View all »Recent Releases

Jul 23, 2015
Anacor Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 6, 2015

Jul 13, 2015
Anacor Pharmaceuticals Announces Positive Top-Line Results From Two Phase 3 Pivotal Studies of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis

View all »Events & Presentations

Aug 6, 2015 at 2:00 PM PT
Anacor Second Quarter 2015 Financial Results Conference Call

Jul 13, 2015 at 4:30 AM PT
Anacor Pharmaceuticals, Inc. Update

Jun 10, 2015 at 3:20 PM PT
Goldman Sachs 36th Annual Global Healthcare Conference

Receive Email Alerts

Sign up to receive e-mail alerts whenever Anacor posts new information to the site.



(ANAC): NASDAQ
Price: 148.70 Change: -1.56
High: 151.46 %Change: 1.038%
Low: 143.43 Volume: 619,600